Company
Vision
AI.ble Therapeutics Inc. believes that people can live free from the fear of dementia,
by combining new ideas and AI technologies.
We’re developing a integrative digital platform to prevent, diagnose, manage and treat neuropsychiatric diseases,
hoping for more and more people can benefit from our service.
AIble in Media
History
AugA patent registered in Taiwan for Speech-based dementia diagnosis
JunStarted a clinical trial to collect speech data in Mandarin with Show Chwan Memorial Hospital in Taiwan
MayA patent registered in Korea for cognitive-motor training program
MayAcquired GS Certification Level 1
AprA patent registered in Korea for speech-based dementia diagnosis (refined)
AprSelected for KISED 2023 Innovative Startup Package
MarSelected for KISA-DB Insurance Insuretech Startup Incubation Program
MarSelected for Shinhan Bank Square Bridge 2023 Incheon AC Program
MarA patent registered in Korea for drawing-based dementia diagnosis
FebContracted for a clinical trial with Show Chwan Memorial Hospital in Taiwan to collect speech data in Mandarin
DecRaised Follow funding
DecStarted a clinical trial of "Cognimo" with the Catholic University of Korea Eunpyeong St. Mary's Hospital
DecStarted Spick PoC at Daekyo Newif senior care centers
SepSelected for Korea International Trade Association 2022 GSS Startup Program
AugSelected for the Ministry of Science and ICT K-Global AC Program
JulSelected for Daekyo x Kyobo Insurance Age-Tech Wave Open Innovation Program
JunAcquired GMP (Good Manufacturing Process) for Spick
AprSelected for the Ministry of Health and Welfare R&D Project
FebSelected for the Ministry of SMEs and Startups R&D project
DecSelected for BE Health Ventures x SCMH AC Program in Taiwan
NovA U.S patent applied for speech-based dementia diagnosis
OctRaised Seed Funding
JulA patent registered in Korea for speech-based dementia diagnosis
JunSelected for Sports Industry Accelerating Program by Korea Sports Promotion Foundation
AprTop 6 finalist at D.Camp startup pitch competition
MarWon the first prize in ICT idea competition hosted by the Ministry of Science and ICT
FebAI.ble Therapeutics established
JanCompleted the 2nd clinical trial (1,300 subjects in 11 hospitals)
Started the 2nd clinical trial
Completed the 1st clinical trial
Started the 1st clinical trial to collect speech data
Completed the development of a speech-based dementia diagnosis algorithm
Started the research and development of a speech-based dementia diagnosis
Members
Prof. Kim, Woojun (CSO)
The Catholic Univ. Of Korea Seoul St.Mary's HospitalCheon, Hosang (CXO)
UI·UX ExpertProf. Kim, Jaewon (CTO)
Seoul National University HospitalProf. Lim, Junsik (CTO)
Gachon UniversityShin, Youjin
Business StrategyChung, Jaehoon
Chief EngineerKim, Hyosun
Full-stack EngineerHong, Suhun
AI EngineerBaek, Chaneun
AI EngineerAdvisory Group
Prof. Yang, Dongwon
The Catholic Univ. Of Korea Seoul St.Mary's HospitalSeoul Metropolitan Center for Dementia
Prof. Shim, Yongsoo
The Catholic Univ. Of Korea Eunpyeong St.Mary's HospitalSeoul Metropolitan Center for Dementia
Prof. Park, Jihye
The Catholic Univ. Of Korea Eunpyeong St.Mary's HospitalKorean Society for NeuroRehabilitation